Researchers at Emory University say that a class of antibiotics, known as fluoroquinolones can enhance RNA interference, the gene-silencing tool that can treat a variety of diseases if adapted in humans.
The researchers have said that the antibiotics can make RNA interference more effective in the laboratory and reduce potential side effects.
Resistance to Antibiotics Found Naturally in Arctic Birds
Arctic birds were carriers of antibiotics-resistant bacteria, signifying that resistance to antibiotics has spread into nature, which can be dangerous for future health care.
Advertisement
"The surprising aspect is that some fluoroquinolones have this previously unrecognized property. The good part is that doctors have years of experience treating bacterial infections with them, so they are generally considered safe," the Nature has quoted senior author Peng Jin, PhD, assistant professor of human genetics at Emory University School of Medicine, as saying.
Enoxacin was found to be the most powerful enhancer of RNA interference which has been used to treat gonorrhea and urinary tract infections. This particular group of compounds also includes the widely used antibiotic ciprofloxacin.
![Ration Antibiotics to Fight Superbugs: Experts]( "Ration Antibiotics to Fight Superbugs: Experts")
Health experts have called for rationing of medicines for patients in a bid to halt the spread of hospital superbugs.
However, it seems that the antibiotics' effect on RNA interference is chemically separate from their bacteria-killing activities. Still, Jin said that significant barriers prevent RNA interference from working well in people
"The barriers include specificity and toxicity, as well as getting the RNA to the right place in the body. If we can enhance how potent a given amount of RNA is and reduce dosage, we're tackling both specificity and toxicity," he said.
Earlier studies have found that side effects result depending on the amount of RNA injected, which can trigger an anti-viral response, instead of the genetic sequence of the RNA used.
The 2006 Nobel Prize in Medicine went to Andrew Fire and Craig Mello for their discovery that short pieces of RNA, when introduced into cells, can silence a stretch of genetic code. Artificially introduced RNA hijacks machinery inside the cell called the RNA-induced silencing complex or RISC.
In order to know the working of RISC, the researchers inserted a gene for a fluorescent protein into a cell line, and later added a short piece of RNA that incompletely silences the inserted gene. That way, if a potential drug tweaked the silencing process, the researchers could see it quickly.
It was found that enoxacin can increase how well a gene is silenced by up to a factor of ten in cultured cells and by a factor of three in mice. It appears to strengthen the grip of part of RISC, a protein called TRBP, upon small pieces of RNA.
The results will be published online in the journal Nature Biotechnology.
Source: ANI
RAS/L
Ration Antibiotics to Fight Superbugs: Experts
Health experts have called for rationing of medicines for patients in a bid to halt the spread of hospital superbugs.
Advertisement
However, it seems that the antibiotics' effect on RNA interference is chemically separate from their bacteria-killing activities. Still, Jin said that significant barriers prevent RNA interference from working well in people
"The barriers include specificity and toxicity, as well as getting the RNA to the right place in the body. If we can enhance how potent a given amount of RNA is and reduce dosage, we're tackling both specificity and toxicity," he said.
Earlier studies have found that side effects result depending on the amount of RNA injected, which can trigger an anti-viral response, instead of the genetic sequence of the RNA used.
The 2006 Nobel Prize in Medicine went to Andrew Fire and Craig Mello for their discovery that short pieces of RNA, when introduced into cells, can silence a stretch of genetic code. Artificially introduced RNA hijacks machinery inside the cell called the RNA-induced silencing complex or RISC.
In order to know the working of RISC, the researchers inserted a gene for a fluorescent protein into a cell line, and later added a short piece of RNA that incompletely silences the inserted gene. That way, if a potential drug tweaked the silencing process, the researchers could see it quickly.
It was found that enoxacin can increase how well a gene is silenced by up to a factor of ten in cultured cells and by a factor of three in mice. It appears to strengthen the grip of part of RISC, a protein called TRBP, upon small pieces of RNA.
The results will be published online in the journal Nature Biotechnology.
Source: ANI
RAS/L
Mechanism Behind Reduction of Neuronal Cell Death by Antibiotics Identified
Researchers from Virginia Commonwealth University have reported the discovery of a mechanism explaining how an antibiotic works to modulate the activity of a neurotransmitter that
Advertisement
Advertisement
|
Advertisement
Recommended Readings
Latest Drug News
The psychedelic market set for remarkable growth, projected to hit $7.2B by 2029 with a strong 55% CAGR.
The study explores whether CDNF could influence the progression of ALS in rodent models and to elucidate the mechanism through which it operates.
Amoxicillin-clavulanate use in acute sinusitis patients is associated with a higher incidence of adverse events.
Professionals advocate for enhanced education of patients and caregivers, and creation of more effective child-resistant systems for monitoring ADHD medication.
In June, WHO raised concerns about 7 Indian cough syrups after complaints from several countries about contamination and health issues.
